SOPHIE is brought to you by Innovation Factory
Systemic Therapeutics Corp logo

About us

Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease. Systemic is pioneering a new approach to the care of metabolic disorders.

Program engagement

Systemic Therapeutics


Rick Austin

Co-Founder, Executive Chairman and Chief Scientific Officer

Jakob Magolan

Co-Founder and Vice President, Drug Discovery

Guillaume Paré

Co-Founder and Chief Medical Officer

Mark Tarnopolsky

Co-Founder and Vice President, Business Development


Intellectual Property